Introduction {#sec1}
============

Imidazoles are the most valuable five-membered heterocyclic compounds found in many natural products, biological systems, pharmaceuticals, and agro chemicals.^[@ref1],[@ref2]^ Additionally, imidazole derivatives have been reported to possess pharmacological properties such as antiplasmodial,^[@ref3]^ antitumor,^[@ref4]^ and antifungal.^[@ref5]^ Consequently, many efforts have been made in the past decade on the synthesis of those privileged scaffolds. The reported methods include reaction of amidines with halo (nitro)alkenes,^[@ref6]^ haloketones,^[@ref7]^ alkyne/haloakynes,^[@ref8]^ and other methods.^[@ref9]^ Although these methods are elegant and appear to be developed specifically for obtaining multisubstituted imidazole derivatives, in organic synthesis, the site-selective synthesis of the desired products is still an attractive and challenging task. Our intention is to develop a method for selective synthesis of 2,4-disubstituted imidazoles using easily available starting reagents under mild reaction conditions. Hence, the synthesis of imidazoles with free N--H and C-5 position for further (N1 and C-5) functionalization of such scaffolds is of continued interest.

Results and Discussion {#sec2}
======================

Despite these advances, to our knowledge, the oxidative cyclization of vinyl azides with benzamidines has remained elusive in literatures. In continuation of our studies on the synthesis of fused N-heterocycles,^[@ref10]^ we report herein a facile method for the synthesis of 2,4-disubstituted imidazoles with 1,8-diazabicyclo(5,4,0)undec-7-ene (DBU) promoted by the oxidative cyclization of vinyl azides with benzamidines under mild conditions ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![](ao-2017-00969n_0001){#sch1}

We began our study by taking benzimidamide hydrochloride (**1a**) and (1-azidovinyl) benzene (**2a**) as the model substrates. The results are summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Initially, the reaction of **1a** and **2a** was performed using 10 mol % of iodine as catalyst in acetonitrile at room temperature for 8 h; the desired product (**3a**) formation was not observed ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). When the reaction was carried out at 65 °C, with 20 mol % of catalyst, trace amount of **3a** was observed ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 2). Under the same conditions, when K~2~CO~3~ was used as a base, 23% yields of the desired product **3a** was isolated ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3). A similar yield was observed without the iodine source ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). In view of this reaction, we turned our attention to vary the reaction temperature (to 80 °C) and other common solvents such as 1,2-dichloroethane (DCE), dimethylformamide (DMF), dimethyl sulfoxide (DMSO), and toluene; consequently, the yield varied between 45 and 67% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 5--9). Further, we screened various inorganic and organic bases (Na~2~CO~3~, Cs~2~CO~3~, *t*BuOK, Et~3~N, DBU, DBN, and DABCO) in acetonitrile as the solvent ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 10--16) \[DBN: 1,5-diazabicyclo\[4,3,0\]non-5-ene; DABCO: 1,4-diazabicyclo\[2.2.2\]octane\]. Interestingly, with DBU as the base, 89% yield of the desired product was obtained (entry 14). No further improvement in the yield was observed while performing the reaction with other solvents such as DMSO, *N*-methyl-2-pyrrolidone (NMP), and water with DBU as the base ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 17--19). The reaction without DBU in acetonitrile as the solvent, no product formation was observed (entry 20). After screening for various parameters, the optimum conditions identified for the present transformation are as follows: 1.5 equiv of **1a**, 1.0 equiv of **2a**, and 1.5 equiv of DBU as the base in acetonitrile at 80 °C ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 14).

###### Optimization of Conditions for **3a**[a](#t1fn1){ref-type="table-fn"}

![](ao-2017-00969n_0007){#fx29}

  entry   catalyst (mol %)   base (1.5 equiv)   temp (°C)   solvent   yield (%)
  ------- ------------------ ------------------ ----------- --------- -----------
  1       I~2~ (10)                             rt          CH~3~CN    
  2       l~2~ (20)                             65          CH~3~CN   traces
  3       l~2~ (20)          K~2~CO~3~          65          CH~3~CN   23
  4                          K~2~CO~3~          65          CH~3~CN   22
  5                          K~2~CO~3~          80          CH~3~CN   55
  6                          K~2~CO~3~          80          DCE       49
  7                          K~2~CO~3~          80          DMF       67
  8                          K~2~CO~3~          80          DMSO      55
  9                          K~2~CO~3~          80          toluene   45
  10                         Na~2~CO~3~         80          CH~3~CN   51
  11                         Cs~2~CO~3~         80          CH~3~CN   42
  12                         *t*BuOK            80          CH~3~CN   61
  13                         Et~3~N             80          CH~3~CN   44
  14                         DBU                80          CH~3~CN   89
  15                         DBN                80          CH~3~CN   73
  16                         DABCO              80          CH~3~CN   69
  17                         DBU                80          DMSO      72
  18                         DBU                80          NMP       65
  19                         DBU                80          H~2~O     45
  20                                            80          CH~3~CN   nr

Reaction conditions, unless otherwise stated: 0.3 mmol of **1a**, 0.2 mmol of **2a**, 0.3 mmol of base, and 2 mL of solvent were placed in a reaction tube, 8 h, isolated yield.

Under the optimized reaction conditions, the scope and generality of the reaction were investigated and the results are summarized in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. Initially, we performed the reaction of benzimidamide hydrochloride (**1a**) with various vinyl azides **2** and the reactions were found to be very facile with both electron-rich and electron-deficient groups (−Me, −OMe, −*t*Bu, −Br, and −F) at the para position of vinyl azides and the desired products **3b**--**f** were obtained in good to excellent yields (80--94%). One of the product **3f** was also confirmed by the single-crystal X-ray diffraction analysis (CCDC No. 1556865). The presence of −NO~2~, −Me, or −OMe group at either the ortho or meta position of vinyl azides produced the corresponding products **3g**--**j** in moderate to good yields (67--79%).

![Substrate Scope of Various Vinyl Azides with Benzamidine (**1a**)\
Reaction conditions: 0.3 mmol of **1a**, 0.2 mmol of **2**, 0.3 mmol DBU, 2.0 mL CH~3~CN were placed in a reaction tube at 80° C, 8 h, isolated yields.](ao-2017-00969n_0002){#sch2}

To expand the scope of the present transformation, we explored the reactivity of the substituted benzamidines substrate with various vinyl azides, and the results are compiled in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. The electron-donating and electron-withdrawing (−Me, −Br, −Cl, and −NO~2~) substituents at the para position of benzamidine reacted smoothly with (1-azidovinyl) benzene and produced the corresponding products **5a**--**d** in good yields (66--87%). Interestingly, the presence of strong electron-donating benzamidines such as 4-aminobenzimidamide hydrochloride and 4-hydroxybenzimidamide hydrochloride reacted with **2a** and gave the products **5e** and **5f** in 70 and 33% yields, respectively. Interestingly, the procedure is amenable to nicotinimidamide hydrochloride and cyclopropane carboximidamide and affords the differently decorated products **5g** and **5h** in 60 and 72% yield, respectively. Additionally, we evaluated the substrate scope of various benzamidines as well as vinyl azides (having both electron-rich and electron-deficient groups in both the rings at either position ortho/meta/para), which afforded the desired products **5i**--**r** in good yields (63--92%). The presence of electron-releasing groups (**5n**), electron-withdrawing groups (**5o** and **5p**), or halogens (**5l** and **5o**) on both the rings provided good yields of products. The results from [Schemes [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"} and [[3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} demonstrate the versatility of the reactions with a high degree of functional group tolerance and with a broad substrate scope. It may be noted that halide-substituted derivatives were well tolerated and could be further applied in traditional cross-coupling reactions. Unfortunately, the present transformation is not suitable for aliphatic benzimidamides with vinyl azide.

![Substrate Scope of Various Benzamidines and Vinyl Azides\
Reaction conditions: 0.3 mmol of **4**, 0.2 mmol of **2**, 0.3 mmol of base, and 2 mL of solvent were placed in a reaction tube, isolated yields, DBU as a base and CH~3~CN as a solvent, 8 h.\
Dry acetonitrile was used.](ao-2017-00969n_0003){#sch3}

To validate the process for scale-up studies (gram scale), we performed the reaction of **1a** with 1-(1-azidovinyl)-4-bromobenzene under optimized conditions and obtained the corresponding product **3f** in 72% yield (2.15 g) ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). This study indicates the feasibility of the method for industrial/commercial production.

![Gram Scale Preparation](ao-2017-00969n_0004){#sch4}

To gain further insight into the reaction mechanism, some control experiments were performed ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}). The reaction of *N*-phenylbenzimidamide **6a** was subjected with **2a** under standard conditions, expect product **7a** was not observed ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, eq 1). This reaction suggests that the free NH~2~ group (of amidine) is essential for such a transformation.^[@cit8b]^ Further, the reaction of **1a** with (1-bromovinyl) benzene (**8**) was conducted under optimized conditions; no reaction was observed, but 91% of **8** was recovered ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, eq 2). It indicates that the direct removal of azide was not possible; the reaction may proceed via nitrene intermediate from vinyl azide ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, eq 3). To ascertain whether the reaction proceeds by radical pathway or not, the reaction of **1a** and **2a** was checked with 2,2,6,6-tetramethylpiperidine-1-oxyl radical under optimized conditions, 86% of **3a** was isolated. This rule outs the radical reaction route. Finally, benzimidamide **9** subjected with **2a** in CH~3~CN without DBU, 91% of the desired product **3a** was obtained ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, eq 4). This reaction and eq 1 ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}) together clarify the necessity of NH~2~ (amidine) in the present transformation. Hence, the role of DBU is to neutralize the hydrochloride of **1a** (benzimidamide hydrochloride).

![Control Experiments](ao-2017-00969n_0005){#sch5}

On the basis of the control experiments and literature reports,^[@ref11]^ a plausible reaction mechanism has been proposed ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). Initially, benzimidamide hydrochloride (**1a**) neutralization by base (DBU) gives benzimidamide **9**. The nucleophilic addition of **9** with (1-azidovinyl) benzene (**2a**) gives the intermediate **I** by the loss of N~2~. The intermediate **I** undergoes cyclization (intermediate **II**) and the subsequent elimination of ammonia afford the desired product **3a**.

![Plausible Mechanism](ao-2017-00969n_0006){#sch6}

Conclusions {#sec3}
===========

In conclusion, we have demonstrated a new simple method for the synthesis of 2,4-disubstituted imidazole derivatives through \[3 + 2\] cyclization of benzamidines with vinyl azides. This methodology is applicable for the selective synthesis of 2,4-disubstituted imidazoles in good to excellent yields, with a high degree of functional group tolerance.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All of the commercially available chemicals and reagents were used without any further purification unless otherwise indicated. ^1^H and ^13^C NMR spectra were recorded at 500, 600 and 125, 150 MHz, respectively. The spectra were recorded in CDCl~3~ and DMSO-*d*~6~, as well as CD~3~OD as a solvent. Multiplicity was indicated as follows: s (singlet); d (doublet); t (triplet); m (multiplet); dd (doublet of doublets), and so on. Coupling constant (*J*) was given in Hz. Chemical shifts are reported in δ relative to tetramethylsilane as an internal standard. The peaks around δ values of 7.26 (^1^H NMR) and 77.0 (^13^C NMR) correspond to CDCl~3~. The peaks around δ values of 2.50 (^1^H NMR) and 39.9 (^13^C NMR) correspond to DMSO. The peak around δ values of 3.35 (^1^H NMR) correspond to H~2~O present in DMSO solvent. The peaks around δ values of 4.78 and 3.20 (^1^H NMR) and 47.5 (^13^C NMR) correspond to CD~3~OD. Progress of the reactions was monitored by thin-layer chromatography (TLC). Silica gel 100--200 mesh size was used for column chromatography using a hexane/ethyl acetate eluent unless otherwise indicated.

General Procedure for **3a** {#sec4.2}
----------------------------

Benzimidamide hydrochloride **1a** (47 mg, 0.3 mmol), (1-azidovinyl) benzene **2a** (29 mg, 0.2 mmol), and DBU (45.6 mg, 0.3 mmol) were taken in a 10 mL reaction tube; to the mixture, 2.0 mL of acetonitrile was added. The reaction tube was placed in a preheated oil bath at 80 °C for 8 h (progress of the reaction was monitored by TLC). Then, the reaction mixture was allowed to attain room temperature; 10.0 mL of brine solution was extracted with ethyl acetate (3 × 15 mL) and dried with anhydrous Na~2~SO~4~. After the removal of solvent, the crude mixture was subjected to column chromatography on silica gel and 89% yield of the product 2,4-disubstituted imidazole (39.2 mg) **3a** was isolated. (All of the vinyl azides employed in the present work were prepared by known procedure.^[@ref12]^)

Characterization Data {#sec4.3}
---------------------

### 2,4-Diphenyl-1*H*-imidazole (**3a**) {#sec4.3.1}

![](ao-2017-00969n_0009){#fx1}

(Eluent: 10% EtOAc/hexane); 89% yield (39.2 mg); white solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 2H), 7.75 (d, *J* = 7.0 Hz, 2H), 7.42--7.33 (m, 6H), 7.26 (t, *J* = 4.0 Hz, 1H). ^13^C NMR (125 MHz, CDCl~3~) δ 147.0, 130.0,128.8, 128.7, 127.0, 125.2, 124.9. HRMS calcd for C~15~H~13~N~2~: 221.1079. Found: 221.1080.

### 2-Phenyl-4-(*p*-tolyl)-1*H*-imidazole (**3b**) {#sec4.3.2}

![](ao-2017-00969n_0010){#fx2}

(Eluent: 10% EtOAc/hexane); 91% yield (42.8 mg); light yellow solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.87 (d, *J* = 8.0 Hz, 2H), 7.63 (d, *J* = 7.0 Hz, 2H), 7.41 (t, *J* = 7.5 Hz, 2H), 7.26 (t, *J* = 7.5 Hz, 2H), 7.20 (d, *J* = 8.0, 2H), 2.36 (s, 3H). ^13^C NMR (125 MHz, CDCl~3~) δ 146.8, 130.1, 129.4, 128.8, 128.7, 125.2, 124.8, 21.2. HRMS calcd for C~19~H~20~NO~2~: 235.1235. Found: 235.1236.

### 4-(4-(*tert*-Butyl)phenyl)-2-phenyl-1*H*-imidazole (**3c**) {#sec4.3.3}

![](ao-2017-00969n_0011){#fx3}

(Eluent: 10% EtOAc/hexane); 94% yield (47.1 mg); light yellow solid; ^1^H NMR (600 MHz, CD~3~OD) δ 7.90 (d, *J* = 6.5 Hz, 2H), 7.66 (d, *J* = 7.0 Hz, 2H), 7.43 (t, *J* = 6.0 Hz, 2H), 7.36 (t, *J* = 6.0 Hz, 1H), 7.32 (s, 1H), 6.94 (d, *J* = 7.5 Hz, 2H), 3.28 (s, 3H). ^13^C NMR (150 MHz, CD~3~OD) δ159.1, 147.0, 130.0, 128.5, 128.4, 126.1, 125.3, 113.8, 54.4. HRMS calcd for C~16~H~15~N~2~O: 251.1184. Found: 251.1180.

### 4-(4-(*tert*-Butyl)phenyl)-2-phenyl-1*H*-imidazole (**3d**) {#sec4.3.4}

![](ao-2017-00969n_0012){#fx4}

(Eluent: 10% EtOAc/hexane); 89% yield (49.3 mg); white solid; melting point 204 °C ^1^H NMR (600 MHz, CD~3~OD) δ 7.91 (d, *J* = 6.0 Hz, 2H), 7.67 (d, *J* = 6.5 Hz, 2H), 7.45 (d, *J* = 6.5 Hz, 1H), 7.42 (d, *J* = 3.5, 2H), 7.40 (s, 1H), 7.39 (s, 1H), 7.36 (t, *J* = 6.5, 1H), 1.39 (s, 9H). ^13^C NMR (150 MHz, CD~3~OD) δ 149.8, 147.3, 130.1, 128.5, 128.4, 125.3, 125.2, 124.5, 34.0, 30.4. HRMS calcd for C~19~H~20~N~2~Na: 299.1524. Found: 299.1510.

### 4-(4-Fluorophenyl)-2-phenyl-1*H*-imidazole (**3e**) {#sec4.3.5}

![](ao-2017-00969n_0013){#fx5}

(Eluent: 10% EtOAc/hexane); 81% yield (38.6 mg); white solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.89 (d, *J* = 8.0 Hz, 2H), 7.75 (s, 1H), 7.46 (t, *J* =7.5 Hz, 2H), 7.39 (t, *J* = 7.0 Hz, 1H), 7.33 (s, 1H), 7.26 (s, 2H), 7.09 (t, *J* = 8.5, 2H). ^13^C NMR (125 MHz, CDCl~3~) δ 147.0, 129.9, 128.9, 126.6, 126.5, 125.2, 115.6, 115.4. HRMS calcd for C~15~H~11~N~2~FNa: 261.0804. Found: 261.0794.

### 4-(4-Bromophenyl)-2-phenyl-1*H*-imidazole (**3f**) {#sec4.3.6}

![](ao-2017-00969n_0014){#fx6}

(Eluent: 10% EtOAc/hexane); 80% yield (47.9 mg); yellow solid; ^1^H NMR (600 MHz, CD~3~OD) δ 7.90 (d, *J* = 6.5 Hz, 2H), 7.67 (d, *J* = 7.0 Hz, 2H), 7.50 (s, 1H), 7.48 (d, *J* = 2.5 Hz, 2H), 7.44 (t, *J* = 6.0, 2H), 7.37 (t, *J* = 6.0 Hz, 2H), 7.37 (t, *J* = 6.0 Hz, 1H). ^13^C NMR (150 MHz, CD~3~OD) δ 147.7, 131.4, 130.0, 128.63, 126.60, 126.4, 125.4, 120.0. HRMS calcd for C~15~H~12~N~2~Br: 299.0184. Found: 294.0172.

### 2-Phenyl-4-(*o*-tolyl)-1*H*-imidazole (**3g**) {#sec4.3.7}

![](ao-2017-00969n_0015){#fx7}

(Eluent: 10% EtOAc/hexane); 72% yield (33.8 mg); yellow solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.89 (d, *J* = 7.5 Hz, 2H), 7.44 (t, *J* = 7.5 Hz, 2H), 7.37 (t, *J* = 7.0, 1H), 7.26 (q, *J* = 6.0 Hz, 5H), 2.50 (s, 3H).^13^C NMR (125 MHz, CDCl~3~) δ 147.1, 135.4, 130.8, 128.8, 128.7, 128.3, 127.4, 126.0, 125.2, 29.7. HRMS calcd for C~16~H~15~N~2~: 235.1235. Found: 235.1241.

### 4-(2-Methoxyphenyl)-2-phenyl-1*H*-imidazole (**3h**) {#sec4.3.8}

![](ao-2017-00969n_0016){#fx8}

(Eluent: 10% EtOAc/hexane); 67% yield (33.5 mg); light yellow solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.88 (d, *J* = 7.5 Hz, 2H), 7.58 (s, 1H), 7.45 (t, *J* = 7.5, 2H), 7.36 (t, *J* = 7.5 Hz, 1H), 7.26 (q, *J* = 7.5, 2H), 7.06 (m, 2H), 4.02 (s, 3H). ^13^C NMR (125 MHz, CDCl~3~) δ 140.0, 128.8, 128.4, 124.9, 121.5, 111.4, 103.5, 55.8. HRMS calcd for C~16~H~15~N~2~O: 251.1184. Found: 251.1178.

### 2-Phenyl-4-(*m*-tolyl)-1*H*-imidazole (**3i**) {#sec4.3.9}

![](ao-2017-00969n_0017){#fx9}

(Eluent: 10% EtOAc/hexane); 79% yield (37.0 mg); yellow solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.87 (d, *J* = 7.5 Hz, 2H), 7.58 (s,1H), 7.51 (d, *J* = 7.5, 1H), 7.39 (t, *J* = 7.5 Hz, 2H), 7.35 (d, *J* = 5.0, 2H), 7.26 (t, *J* = 7.5, 2H), 7.08 (d, *J* = 7.5, 1H), 2.37 (s, 3H). ^13^C NMR (125 MHz, CDCl~3~) δ 146.9, 138.3, 128.8, 128.68, 128.61, 127.8, 125.5, 125.2, 121.9, 21.4. HRMS calcd for C~16~H~15~N~2~: 235.1235. Found: 235.1234.

### 4-(3-Nitrophenyl)-2-phenyl-1*H*-imidazole (**3j**) {#sec4.3.10}

![](ao-2017-00969n_0018){#fx10}

(Eluent: 20% EtOAc/hexane); 67% yield (35.6 mg); brick red color solid; ^1^H NMR (500 MHz, CDCl~3~) δ 8.65 (s, 1H), 8.21 (d, *J* = 7.0 Hz, 1H), 8.11 (d, *J* = 9.0 Hz, 1H), 7.91 (d, *J* = 7.5 Hz, 2H), 7.56 (t, *J* = 8.0 Hz, 1H), 7.51 (s, 1H), 7.48 (t, *J* = 7.5 Hz, 2H), 7.91 (d, *J* = 7.5 Hz, 2H), 7.42 (t, *J* = 7.0 Hz, 1H), 7.26 (s, 1H), 7.56 (t, *J* = 8.0 Hz, 1H). ^13^C NMR (125 MHz, CDCl~3~) δ 147.4, 130.8, 129.5, 129.2, 129.0, 125.3, 121.4, 119.6. HRMS calcd for C~15~H~12~N~3~O~2~: 266.0930. Found: 266.0921.

### 4-Phenyl-2-(*p*-tolyl)-1*H*-imidazole (**5a**) {#sec4.3.11}

![](ao-2017-00969n_0019){#fx11}

(Eluent: 10% EtOAc/hexane); 87% yield (40.8 mg); light yellow solid; ^1^H NMR (500 MHz, CDCl~3~) δ 7.78 (d, *J* = 8.0 Hz, 2H), 7.41 (q, *J* = 7.5 Hz, 3H), 7.26 (q, *J* = 7.5 Hz, 5H), 2.39 (s, 3H). ^13^C NMR (125 MHz, CDCl~3~) δ 147.1, 138.8, 129.5, 128.7, 127.0, 125.1, 124.8, 21.3. HRMS calcd for C~16~H~15~N~2~: 235.1235. Found: 235.1237.

### 2-(4-Bromophenyl)-4-phenyl-1*H*-imidazole (**5b**) {#sec4.3.12}

![](ao-2017-00969n_0020){#fx12}

(Eluent: 10% EtOAc/hexane); 85% yield (50.7 mg); yellow solid; melting point 198 °C ^1^H NMR (500 MHz, CDCl~3~) δ 7.72 (t, *J* = 8.0 Hz, 4H), 7.52 (d, *J* = 8.0 Hz, 2H), 7.40 (q, *J* = 7.5 Hz, 3H), 7.28 (t, *J* = 7.5 Hz, 1H).^13^C NMR (125 MHz, CDCl~3~) δ 146.0, 132.0, 128.9, 128.7, 127.2, 126.7, 124.9, 128.8. HRMS calcd for C~15~H~12~N~2~Br: 299.0184. Found: 299.0186.

### 2-(4-Chlorophenyl)-4-phenyl-1*H*-imidazole (**5c**) {#sec4.3.13}

![](ao-2017-00969n_0021){#fx13}

(Eluent: 10% EtOAc/hexane); 81% yield (41.3 mg); white solid; ^1^H NMR (600 MHz, CD~3~OD) δ 7.88 (d, *J* = 6.5, Hz, 2H), 7.73 (d, *J* = 6.5 Hz, 2H), 7.44 (d, *J* = 6.0 Hz, 3H), 7.37 (t, *J* = 6.5 Hz, 2H), 7.23 (t, *J* = 6.0 Hz, 1H). ^13^C NMR (150 MHz, CD~3~OD) δ 145.9, 134.6, 131.2, 129.1, 128.7, 128.6, 128.5, 126.4, 124.9. HRMS calcd for C~15~H~12~N~2~Cl: 255.0689. Found: 255.0694.

### 2-(4-Nitrophenyl)-4-phenyl-1*H*-imidazole (**5d**) {#sec4.3.14}

![](ao-2017-00969n_0022){#fx14}

(Eluent: 20% EtOAc/hexane); 69% yield (36.6 mg); brick red color solid; ^1^H NMR (600 MHz, CD~3~OD) δ 8.29 (d, *J* = 8.0 Hz, 2H), 8.05 (d, *J* = 8.5 Hz, 2H), 7.77 (d, *J* = 7.5 Hz, 2H), 7.47 (s, 1H), 7.42 (t, *J* = 7.5 Hz, 2H), 7.31 (t, *J* = 7.0, 1H). ^13^C NMR (150 MHz, CD~3~OD) δ 146.3, 134.2, 128.84, 128.73, 128.4, 126.8, 124.7. HRMS calcd for C~15~H~12~N~3~O~2~: 266.0930 Found: 266.0928.

### 4-(4-Phenyl-1*H*-imidazol-2-yl)aniline (**5e**) {#sec4.3.15}

![](ao-2017-00969n_0023){#fx15}

(Eluent: 75% EtOAc/hexane); 70% yield (33.1 mg); gray color solid; melting point 199 °C. ^1^H NMR (600 MHz, CDCl~3~) δ 7.60 (d, *J* = 6.5 Hz, 2H), 7.49 (d, *J* = 6.0 Hz, 2H), 7.33 (d, *J* = 6.0, 2H), 7.26 (s, 1H), 6.97 (s, 1H), 6.42 (d, *J* = 6.0 Hz, 2H). ^13^C NMR (150 MHz, CDCl~3~) δ 150.8, 148.4, 146.4, 127.6, 125.6, 124.8, 114.7. HRMS calcd for C~15~H~14~N~3~: 236.1188. Found: 236.1181.

### 4-(4-Phenyl-1*H*-imidazol-2-yl)phenol (**5f**) {#sec4.3.16}

![](ao-2017-00969n_0024){#fx16}

(Eluent: 65% EtOAc/hexane); 33% yield (15.7 mg); white color solid; ^1^H NMR (600 MHz, DMSO-*d*~6~) δ 12.3 (s, 1H), 9.65 (s, 1H), 7.79 (q, *J* = 6.5 Hz, 4H), 7.61 (s, 1H), 7.31 (t, *J* = 6.5, 2H), 7.14 (t, *J* = 6.0 Hz, 1H), 6.80 (d, *J* = 7.0, 2H). ^13^C NMR (150 MHz, DMSO-*d*~6~) δ 158.1, 135.4, 128.9, 127.0, 126.4, 124.7, 122.4, 115.9, 113.8. HRMS calcd for C15H13N~2~O: 237.1028. Found: 237.1031.

### 3-(4-Phenyl-1*H*-imidazol-2-yl)pyridine (**5g**) {#sec4.3.17}

![](ao-2017-00969n_0025){#fx17}

(Eluent: 80% EtOAc/hexane); 60% yield (26.4 mg); white solid; ^1^H NMR (600 MHz, DMSO-*d*~6~) δ 9.0 (s, 1H), 8.52 (s, 1H), 8.31 (d, *J* = 7.0, 1H), 7.66 (d, *J* = 7.5 Hz, 2H), 7.26 (q, *J* = 7.5, 2H), 7.41 (t, *J* = 5.0 Hz, 3H), 7.35 (t, *J* = 4.0 Hz, 1H), 7.26 (s, 1H). ^13^C NMR (150 MHz, DMSO-*d*~6~) δ 148.8, 146.0, 143.2, 141.4, 134.2, 132.0, 128.8, 128.4, 126.3, 124.3, 123.7, 114.9. HRMS calcd for C~14~H~12~N~3~: 221.1031. Found: 221.1026.

### 2-Cyclopropyl-4-phenyl-1*H*-imidazole (**5h**) {#sec4.3.18}

![](ao-2017-00969n_0026){#fx18}

(Eluent: 30% EtOAc/hexane); 72% yield (26.5 mg); white solid; melting point 160 °C. ^1^H NMR (600 MHz, CDCl~3~) δ 7.64 (broad peak, 2H), 7.35 (t, *J* = 6.5,2H), 7.21 (t, *J* = 6.5, 1H), 7.16 (s, 1H), 1.99--1.94 (m, 1H), 1.02--0.95 (m, 4H). ^13^C NMR (150 MHz, CDCl~3~) δ 128.7, 126.7, 124.7, 9.24, 7.44. HRMS calcd for C~12~H~13~N~2~: 185.1079. Found: 185.1077.

### 4-(4-Fluorophenyl)-2-(*p*-tolyl)-1*H*-imidazole (**5i**) {#sec4.3.19}

![](ao-2017-00969n_0027){#fx19}

(Eluent: 10% EtOAc/hexane); 87% yield (43.8 mg); white solid; melting point 180 °C. ^1^H NMR (600 MHz, CDCl~3~) δ 7.75 (t, *J* = 7.0 Hz, 4H), 7.27 (d, *J* = 8.5 Hz, 1H), 7.22 (d, *J* = 6.5, 2H), 7.06 (t, *J* = 7.0 Hz, 2H), 2.37 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~) δ 162.8 (d, J = 203.6), 138.9, 129.5, 127.2, 126.60 (d, *J* = 6.37 Hz), 125.1, 115.6 (d, *J* = 17.7 Hz), 21.3. HRMS calcd for C~16~H~14~N~2~F: 253.1141. Found: 253.1153.

### 4-(4-Fluorophenyl)-2-(4-nitrophenyl)-1*H*-imidazole (**5j**) {#sec4.3.20}

![](ao-2017-00969n_0028){#fx20}

(Eluent: 20% EtOAc/hexane); 72% yield (41.0 mg); brick red solid; melting point 216 °C. ^1^H NMR (600 MHz, DMSO-*d*~6~) δ 13.34 (s, 1H), 8.70 (s, 1H), 8.37 (d, *J* = 7.0 Hz, 2H), 8.34 (d, *J* = 6.5, 1H), 8.28 (d, *J* = 7.5 Hz, 2H), 8.24 (s, 1H), 8.10 (d, *J* = 7.0 Hz, 1H), 7.70 (t, *J* = 7.0 Hz, 1H). ^13^C NMR (150 MHz, DMSO-*d*~6~) δ 148.8, 147.2, 144.9, 144.8, 140.6, 136.4, 131.2, 130.7, 126.3, 124.9, 121.6, 119.0, 118.6. HRMS calcd for C~15~H~11~N~3~O~2~F: 284.0835. Found: 284.0836.

### 4-(4-Bromophenyl)-2-(*p*-tolyl)-1*H*-imidazole (**5k**) {#sec4.3.21}

![](ao-2017-00969n_0029){#fx21}

(Eluent: 10% EtOAc/hexane); 92% yield (57.7 mg); light yellow solid; melting point 210 °C. ^1^H NMR (600 MHz, CD~3~OD) δ 7.79 (d, *J* = 6.5 Hz, 2H), 7.67 (d, *J* = 7.5 Hz, 2H), 7.51 (d, *J* = 6.5, 2H), 7.47 (s, 1H), 7.27 (d, *J* = 6.5, 2H), 2.36 (s, 3H). ^13^C NMR (150 MHz, CD~3~OD) δ 149.2, 140.1, 132.6, 130.4, 128.4, 127.6, 126.6, 121.2, 21.2. HRMS calcd for C~16~H~14~N~2~Br: 313.0340. Found: 313.0349.

### 4-(4-Bromophenyl)-2-(4-chlorophenyl)-1*H*-imidazole (**5l**) {#sec4.3.22}

![](ao-2017-00969n_0030){#fx22}

(Eluent: 10% EtOAc/hexane); 79% yield (52.4 mg); light yellow solid; melting point 200 °C. ^1^H NMR (600 MHz, CDCl~3~) δ 7.78 (d, *J* = 6.5 Hz, 2H), 7.64 (d, *J* = 6.5 Hz, 2H), 7.51 (d, *J* = 6.5, 2H), 7.38 (d, *J* = 7.0 Hz, 2H), 7.34 (s, 1H), 7.25 (s, 1H). ^13^C NMR (150 MHz, CDCl~3~) δ 146.1, 134.8, 131.7, 129.1, 128.2, 126.5, 120.8. HRMS calcd for C~15~H~11~N~2~ClBr: 332.9794. Found: 332.9796.

### 4-(4-Chlorophenyl)-2-cyclopropyl-1*H*-imidazole (**5m**) {#sec4.3.23}

![](ao-2017-00969n_0031){#fx23}

(Eluent: 10% EtOAc/hexane); 67% yield (29.4 mg); white solid; melting point 164 °C. ^1^H NMR (600 MHz, DMSO-*d*~6~) δ 11.90 (s, 1H),7.73 (s, 1H), 7.65 (d, *J* = 5.0 Hz,1H), 7.54 (s, 1H), 7.33 (t, *J* = 6.5 Hz, 1H), 7.18 (d, *J* = 6.0 Hz, 1H), 1.97--1.93 (m, 1H), 0.92--0.90 (m, 2H), 0.89--0.85 (m, 2H). ^13^C NMR (150 MHz, DMSO-*d*~6~) δ 130.7, 125.8, 124.0, 123.0, 113.4, 9.6, 7.5. HRMS calcd for C~19~H~20~NO~2~: 219.0689. Found: 219.0690.

### 4-(4-(4-(*tert*-Butyl)phenyl)-1*H*-imidazol-2-yl)aniline (**5n**) {#sec4.3.24}

![](ao-2017-00969n_0032){#fx24}

(Eluent: 75% EtOAc/hexane); 72% yield (42.3 mg); gray color solid; melting point 218 °C. ^1^H NMR (600 MHz, DMSO-*d*~6~) δ 12.16 (s, 1H), 7.76 (s, 2H), 7.72 (s, 2H),7.53 (s, 1H), 7.43 (s, 2H), 6.67 (t, *J* = 2.5 Hz, 2H), 5.39 (s, 2H), 1.36 (s, 9H). ^13^C NMR (150 MHz, DMSO-*d*~6~) δ 149.4, 126.7, 125.6, 124.4, 114.1, 31.7. HRMS calcd for C~19~H~22~N~3~: 292.1814. Found: 292.1815.

### 2, 4-Bis(4-bromophenyl)-1*H*-imidazole (**5o**) {#sec4.3.25}

![](ao-2017-00969n_0033){#fx25}

(Eluent: 10% EtOAc/hexane); 85% yield (64.2 mg); yellow color solid; melting point 194 °C. ^1^H NMR (600 MHz, CDCl~3~) δ 7.85 (d, *J* = 8.5 Hz, 2H), 7.75 (d, *J* = 6.5 Hz, 2H), 7.64 (d, *J* = 9.5, 2H), 7.58 (d, *J* = 8.5 Hz, 2H), 7.39 (s, 1H). ^13^C NMR (150 MHz, CDCl~3~) δ 146.0, 132.1, 137.7, 128.7, 126.7, 126.5, 123.0, 120.8. HRMS calcd for C~15~H~11~N~2~Br~2~: 376.9289. Found: 376.9285.

### 4-(3-Nitrophenyl)-2-(4-nitrophenyl)-1*H*-imidazole (**5p**) {#sec4.3.26}

![](ao-2017-00969n_0034){#fx26}

(Eluent: 85% EtOAc/hexane); 69% yield (43.1 mg); brick red color solid; ^1^H NMR (600 MHz, CD~3~OD) δ 8.60 (s, 1H), 8.25 (d, *J* = 7.5 Hz, 2H), 8.10 (q, *J* = 6.5, 3H), 8.02 (d, *J* = 6.5 Hz, 1H), 7.74 (s, 1H), 7.54 (t, *J* = 7.0 Hz, 1H). ^13^C NMR (150 MHz, CD~3~OD) δ 148.7, 147.5, 145.4, 135.5, 130.4, 129.5, 125.7, 123.7, 121.0, 118.9. HRMS calcd for C~15~H~11~N~4~O~4~: 311.0780. Found: 311.0779.

### 2-(4-Bromophenyl)-4-(2-methoxyphenyl)-1*H*-imidazole (**5q**) {#sec4.3.27}

![](ao-2017-00969n_0035){#fx27}

(Eluent: 10% EtOAc/hexane); 63% yield (41.4 mg); yellow solid; melting point 198 °C. ^1^H NMR (600 MHz, CD~3~OD) δ 7.87 (d, *J* = 6.0 Hz, 1H), 7.83 (d, *J* = 7.5 Hz, 2H), 7.61 (d, *J* = 7.5, 2H), 7.55 (s, 1H), 7.24 (t, *J* = 6.0 Hz, 1H), 7.06 (d, *J* = 7.0, 1H), 7.00 (t, *J* = 6.0 Hz, 1H) 3.92 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~) δ 152.8, 143.8, 131.1, 128.3, 125.4, 121.5, 55.0. HRMS calcd for C~16~H~14~N~2~OBr: 329.0289. Found: 329.0280.

### 2-(4-Chlorophenyl)-4-(*o*-tolyl)-1*H*-imidazole (**5r**) {#sec4.3.28}

![](ao-2017-00969n_0036){#fx28}

(Eluent: 10% EtOAc/hexane); 70% yield (37.6 mg); light yellow solid; melting point 191 °C. ^1^H NMR (600 MHz, CD~3~OD) δ 7.80 (d, *J* = 7.5 Hz, 2H), 7.43 (m, 2H), 7.36 (d, *J* = 6.5, 2H), 7.18 (m, 2H), 7.14 (m, 2H), 7.10 (s, 1H) 2.34 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~) δ 145.5, 135.7, 134.2, 130.3, 128.8, 128.7, 127.3, 126.7, 125.5, 19.8. HRMS calcd for C~16~H~14~N~2~Cl: 269.0846. Found: 269.0843.
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